Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis?

Treichel, Markus; Schwendener Scholl, Katharina; Kessler, Ulf; Joeris, Alexander; Nelle, Mathias (2009). Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis? World journal of pediatrics WJP, 5(1), pp. 65-7. Hangzhou: Springer-Verlag 10.1007/s12519-009-0013-6

[img]
Preview
Text
12519_2009_Article_13.pdf - Published Version
Available under License Publisher holds Copyright.

Download (186kB) | Preview

BACKGROUND: Novel antidepressant drugs are increasingly used by women of child bearing age. However, potentially harmful effects on fetus and newborn remain unknown. METHODS: Case report and literature review. RESULTS: We present preterm twins whose mother was treated with venlafaxine, a nonselective serotonin reuptake inhibitor, throughout pregnancy until delivery. The twins developed neonatal necrotizing enterocolitis. CONCLUSION: The question whether there might be a correlation between maternal serotonin reuptake inhibitor therapy and neonatal necrotizing enterocolitis is discussed.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Surgery

UniBE Contributor:

Schwendener Scholl, Katharina; Kessler, Ulf and Nelle, Mathias

ISSN:

1708-8569

ISBN:

19172337

Publisher:

Springer-Verlag

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:03

Last Modified:

26 Jun 2018 14:05

Publisher DOI:

10.1007/s12519-009-0013-6

PubMed ID:

19172337

Web of Science ID:

000262917900013

BORIS DOI:

10.7892/boris.27219

URI:

https://boris.unibe.ch/id/eprint/27219 (FactScience: 105064)

Actions (login required)

Edit item Edit item
Provide Feedback